Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FKEME
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,154
Award facts
- Contract value 100% obligated
- $16,154.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,154.36 by the Defense Logistics Agency (DLA) on September 18, 2025. The order is for Stelara 90 mg/ml syringes, a biologic medication commonly used to treat inflammatory conditions. This delivery order was issued without a set-aside designation and operates under a firm fixed-price structure, with an ultimate completion date of October 9, 2025. The place of performance is located in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations.
This delivery order is issued under DMS Pharmaceutical Group's significant Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support Department of Defense healthcare facilities worldwide. As a established federal contractor since 2001, DMS Pharmaceutical Group has demonstrated consistent capability in delivering specialized pharmaceutical products to military health facilities, positioning the company as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FKEME?
SPE2DB25FKEME was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FKEME worth?
The government has obligated $16,154 on SPE2DB25FKEME.
Is contract SPE2DB25FKEME an order under another contract?
Yes. SPE2DB25FKEME is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKEME competed?
The extent of competition for SPE2DB25FKEME was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award